HIMS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HIMS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Hims & Hers Health's total current assets for the quarter that ended in Dec. 2024 was $396 Mil.
The historical data trend for Hims & Hers Health's Total Current Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Total Current Assets | Get a 7-Day Free Trial | 113.08 | 269.91 | 216.60 | 265.05 | 395.83 |
Hims & Hers Health Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Total Current Assets | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
265.05 | 261.73 | 290.92 | 326.38 | 395.83 |
Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.
Hims & Hers Health's Total Current Assets for the fiscal year that ended in Dec. 2024 is calculated as
Total Current Assets | = | Cash, Cash Equivalents, Marketable Securities | + | Total Receivables | + | Total Inventories | + | Other Current Assets |
= | 300.251 | + | 6.08 | + | 64.427 | + | 25.073 | |
= | 396 |
Hims & Hers Health's Total Current Assets for the quarter that ended in Dec. 2024 is calculated as
Total Current Assets | = | Cash, Cash Equivalents, Marketable Securities | + | Total Receivables | + | Total Inventories | + | Other Current Assets |
= | 300.251 | + | 6.08 | + | 64.427 | + | 25.073 | |
= | 396 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.
Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.
Hims & Hers Health (NYSE:HIMS) Total Current Assets Explanation
In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.
Hims & Hers Health's Liquidation Value for the quarter that ended in Dec. 2024 is
Liquidation value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 300.251 | - | 230.823 | + | 0.75 * 6.08 | + | 0.5 * 64.427 |
= | 106 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Hims & Hers Health's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Andrew Dudum | director, 10 percent owner, officer: Chief Executive Officer | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Oluyemi Okupe | officer: Chief Financial Officer | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Soleil Boughton | officer: See Remarks | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Melissa Baird | officer: Chief Operating Officer | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Irene Becklund | officer: Interim PFO/PAO | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Patrick Harrison Carroll | officer: Chief Medicall Officer | 2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123 |
Christiane Pendarvis | director | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
Michael Chi | officer: Chief Marketing Officer | 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123 |
David B Wells | director | C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130 |
Lynne Chou O'keefe | director | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Alex Bard | director | 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123 |
Ivp Executive Fund Xvi, Llc | 10 percent owner | 3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025 |
Jules A. Maltz | director | 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025 |
Somesh Dash | 10 percent owner | 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025 |
Jack Abraham | 10 percent owner | 1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129 |
From GuruFocus
By GuruFocus News • 04-01-2025
By GuruFocus News • 03-06-2025
By GuruFocus News • 04-11-2025
By GuruFocus News • 04-22-2025
By Khac Phu Nguyen • 03-06-2025
By GuruFocus News • 04-02-2025
By GuruFocus News • 03-18-2025
By GuruFocus News • 04-21-2025
By GuruFocus News • 03-17-2025
By GuruFocus News • 04-02-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.